×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
melanoma
0.800
GenomicAlterations
CGI
×
Entrez Id:
4286
Gene Symbol:
MITF
MITF
melanoma
0.700
GenomicAlterations
CGI
×
Entrez Id:
8314
Gene Symbol:
BAP1
BAP1
melanoma
0.700
GenomicAlterations
CGI
×
Entrez Id:
4763
Gene Symbol:
NF1
NF1
melanoma
0.600
GenomicAlterations
CGI
×
Entrez Id:
595
Gene Symbol:
CCND1
CCND1
melanoma
0.400
GenomicAlterations
CGI
×
Entrez Id:
5058
Gene Symbol:
PAK1
PAK1
melanoma
0.340
GenomicAlterations
CGI
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
26678033
2016
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
23020132
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CGI
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
BRAF and RAS mutations in human lung cancer and melanoma.
12460918
2002
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.
20551065
2010
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.
24576830
2014
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer.
23524406
2013
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy.
24586605
2014
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
We have treated 45 patients with V600 mutated melanoma including patients with V600R mutation between July 2011 and October 2012 with the selective BRAF inhibitor dabrafenib (n=43) or vemurafenib (n=2) via a compassionate access programme.
23237741
2013
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Missense mutations of the BRAF gene in human lung adenocarcinoma.
12460919
2002
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
In summary, we have identified a group of melanomas with low-activity BRAF mutations that are reliant upon CRAF-mediated survival activity.
18794803
2009
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor.
23248257
2013
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
[Long-term results following surgery or radioiodine treatment of solitary autonomous adenoma of the thyroid gland].
2493360
1989
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
22608338
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Prognostic value of BRAF mutations in localized cutaneous melanoma.
24388723
2014
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Here we report BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers.
12068308
2002
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.
24583796
2014
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
23614898
2013
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.
22805292
2012